Profiles (Publications) December 4, 2014 PUBLICATIONS Barry Blackwell

ARTICLES: 1. Blackwell, B.: Why Patients Come to a Casualty Department. Lancet. (1962), 1:369.

2. Blackwell, B.: Acute Leukemia Presenting as a Lump in the Breast. British Journal of Surgery. (1963), 225:769-771.

3. Lehmann, H., Liddell, J., Blackwell, B., O’Connor, D.C., Daws, A.V.: Two Further Serum Pseudocholinesterase Phenotypes as Causes of Suxamethonium Apnoea. British Medical Journal. (1963), 1:1116-1118.

4. Blackwell, B.: Hypertensive Crisis Due to MAOI. Lancet. (1963), 2:849-851.

5. Blackwell, B.: Munchausen at Guy’s. Guy’s Hospital Reports. (1963), 114 (3):257-277.

6. Blackwell, B.: The Management of Barbituate Overdose in Nonspecialized Units. British Journal of Clinical Practice. (1964), 18 (3):135-144.

7. Blackwell, B., Mallett, B.L.: Psychiatric Illness in a Casualty Department. Guy’s Hospital Reports. (1964), 113:123-130.

8. Blackwell, B., Marley, E.: Interaction Between Cheese and MAOI in Rats and Cats. Lancet. (1964), 1:530-531.

9. Blackwell, B., Davis, B.: Psychiatric Aspects of Myclonus Epilepsy. British Journal of Clinical Practice. (1964), 18 (9):513-516.

10. Palmai, G., Blackwell, B.: The Diurnal Pattern of Salivary Flow in Normal and Depressed Patients. British Journal of Psychiatry. (1965), 111:334-338.

11. Blackwell, B., Mabbitt, L.A.: Tyramine in Cheese Related to Hypertensive Crisis after MAOI. Lancet. (1965), 1:938-940.

12. Blackwell, B., Marley, E., Mabbitt, L.A.: Effects of Yeast Extract after MAOI. Lancet. (1965), 1:940-943.

13. Blackwell, B.: The Simplified Management of Barbituate Overdose. International Medical Digest. (1966), 1:41.

1 14. Blackwell, B., Marley, E.: Interactions of Cheese and Its Constituents with MAOI. British Journal of Pharmacology. (1966), 26:142-161.

15. Blackwell, B., Marley, E.: Interactions of Yeast Extracts and Their Constituents with MAOI. British Journal of Pharmacology. (1966), 26:142-161.

16. Palmai, C., Blackwell, B.: The Burgholzi Centenary. Medical History. (1966), 10(3):257-265.

17. Blackwell, B., Marley, E., Price, J., Taylor, D.: Hypertensive Interaction Between MAOI and Foodstuffs. British Journal of Psychiatry. (1967), 113:349-365.

18. Palmai, G., Blackwell, B., Maxwell, A.E., Morgenstern, F.: Patterns of Salivary Flow in Depressive Illness and During Treatment. British Journal of Psychiatry. (1967), 113:1297-1308.

19. Blackwell, B., Marley, E.: Depressor Effects with Sympathomimetic Amines After Blockade of Cardiovascular Receptors. Nature. (1967), 213:840.

20. Blackwell, B., Taylor, D.: An Operational Evaluation of MAOI. Proc. Roy. Soc. Med. (1967), 60:830-833.

21. Blackwell, B., Shephard, M.: Early Evaluation of Psychotropic Drugs in Man. Lancet. (1967), 2:819-822.

22. Blackwell B., Shephard, M.: Prophylactic Lithium: Another Therapeutic Myth? Lancet. (1968), 1:968-971.

23. Samuel, G., Blackwell, B.: MAOI and Cheese: A Process of Discovery. Hospital Medicine. (1968), 2:942-943.

24. Blackwell, B.: Another Amitriptyline Side Effect. Lancet. (1968), 1:426.

25. Blackwell, B.: The Munchausen Syndrome. British Journal of Hospital Medicine. (1968), 1:98-102.

26. Blackwell, B., Goldberg, D.P.: Psychiatric Interviews in General Practice. British Medical Journal. (1968), 4:99-101. (Published also in Practical Psychiatry, British Medical Journal, 1969.)

27. Blackwell, B., Marley, E.: MAOI and Intolerance to Foodstuffs. Bibliotheca. Nutritio et Dieta. (1969), 11:96-110.

28. Blackwell, B.: The Use of Tranquilizers in General Practice. Prescriber’s Journal. (1969), 9:29.

2 29. Blackwell, B., Mabbitt, L.A., Marley, E.: Histamine and Tyramine Content of Yeast Products. Journal of Food Science. (1969), 34:47-51.

30. Blackwell, B.: Why Drugs Don’t Work: Factors Influencing Outcome with Psychotropic Drugs. Medical Counterpoint. (1969), 1:40.

31. Blackwell, B. Walker, K.P.: Possible Pregnancy in General Practice. Practitioner. (1969), 202:691.

32. Blackwell, B.: Lithium: Prophylactic or Panacea? Medical Counterpoint. (1969), 1(8):52-59.

33. Goldberg, D., Blackwell, B.: Psychiatric Illness in General Practice: A Detailed Study Using a New Method of Case Identification. British Medical Journal. (1970), 2:439-443.

34. Blackwell, B., Goldberg, D.: The Use of Psychotropic Drugs in General Practice. Update. (1970), 2(7):927.

35. Blackwell, B.: The Use of Drugs in the Management of Depression. Therapeutic Consult. (1970), 2(2).

36. Blackwell, B., Goldberg, D.: The Patient’s Complaint. Medical Counterpoint. (1970), 2(5):28-38.

37. Blackwell, B., Ayd, F.: Problems of Evaluation of a New Antidepressant Drug in Prison Volunteers. Journal of Clinical Pharmacology and New Drugs. (1971), 2(1):19.

38. Blackwell, B., Sternberg, M.: Trial Management in Psychopharmacology: The Roles and Tasks of an Industry Physician. Journal of Clinical Pharmacology and New Drugs. (1971), 2(2):83-90.

39. Goldberg, D.P., Blackwell, B.: The Management of Psychiatric Illness in General Practice. Update. (1971), 3(3):369.

40. Blackwell, B.: The Scientific and Ethical Problems of Psychotropic Drug Research in Prison Volunteers. Psychopharmacology Bulletin. (1971), 7(4):35.

41. Goldberg, D.P., Blackwell, B.: Psychiatry in General Practice: The Diagnostic Interview in General Practice. Update. (1971), 3(3):239-244.

42. Blackwell, B.: How the Physician Can Influence the Cost of Drugs. Therapeutic Consult. (1971), 3(5&6):9.

3 43. Blackwell, B., Lipkin, J.O., Meyer, J.H., Kuzma, R.: Dose Responses and Relationships Between Anticholinergic Activity and Mood with Tricyclic Antidepressants. Psychopharmacologia. (1972), 25:205-217.

44. Blackwell, B.: For the First Time in Man: A Nationwide Survey of Attitudes to Phase I Research Among Industrial and Academic Scientists. Clinical Pharmacology and Therapeutics. (1972), 13:812.

45. Blackwell, B., Bloomfield, S.S., Buncher, C.R.: Demonstration to Medical Students of Placebo Responses and Non-Drug Factors. Lancet. (1972), 1:1279-1282.

46. Blackwell, B.: The Drug Defaulter. Clinical Pharmacology and Therapeutics. (1972), 13:841-848.

47. Evans, W., Gensler, G., Blackwell, B., Galbrecht, C.: The Effects of Antidepressant Drugs on Pain Relief and Mood in the Chronically Ill. Psychosomatics. (1973), 14:214.

48. Blackwell, B.: Psychotropic Drugs in Use Today: The Role of Diazepam in Medical Practice. Journal of the American Medical Association. (1973), 225:1637-1641.

49. Blackwell, B.: Drug Therapy: Patient Compliance. New England Journal of Medicine. (1973), 289:249-252.

50. Kramer, M., Blackwell, B., Roth, T., Wray, M.: Metiapine in Acute Schizophrenic Patients. Current Therapeutic Research. (1973), 15(7):465- 469.

51. Winstead, D., Blackwell, B., Anderson, A., Eilers, M.K.: Diazepam on Demand: Drug Seeking Behavior in Anxious Inpatients. Archives of General Psychiatry. (1974), 30:349-351.

52. Blackwell, B., Wooley, S.C., Whitehead, W.E.: Psychosomatic Illness: A New Treatment Approach. Cincinnati Journal of Medicine. (1974), 55:95-98.

53. Eilers, M.K., Blackwell, B.: Psychiatric Patients’ Impressions of Teaching Conferences. Journal of Psychiatric Nursing and Mental Health Services. (1974), 12(4):5-9.

54. Lerner, R., Blackwell. B,: Psychiatric Patients: The G.P. as a Psychiatric Community Resource. Journal of Community Mental Health. (1975), 11:3.

4 55. Blackwell, B.: Minor Tranquilizers: Use, Misuse or Overuse. Psychosomatics. (1975), 16:28.

56. Blackwell, B.: A Critical Review of Oxazepam: Efficacy and Specificity. Diseases of the Nervous System. (1975), 36:17.

57. Blackwell, B.: Rational Drug Use in the Management of Anxiety. Rational Drug Therapy. (1975), 9:1.

58. Wooley, S.C., Blackwell, B.: A Behavioral Probe into Social Contingencies on a Psychosomatic Ward. Journal of Applied Behavior Analysis. (1975), 8(3):337-339.

59. Blackwell, B., Stolley, P., Buncher, R., Klimt, C., Temple, R., Venn, D., Wardell, W.: Panel 4: Phase IV Investigations. Clinical Pharmacology and Therapeutics. (1975), 18(5, Part 2):635.

60. Kramer, M., Roth, T., Goldstein, S., Ryan, M., Blackwell, B.: A Double-Blind Evaluation of Metiapine in Hospitalized Acute Schizophrenics. Current Therapeutic Research. (1975), 18(6):839-848.

61. Blackwell, B.: What to Do About the Patient Who Won’t Take His Medicine. Consultant. (1975), 15(2):51-56.

62. Whitehead, W.E., Lurie, E., Blackwell, B.: Classical Conditioning of Decreases in Human Systolic Blood Pressure. Journal of Applied Behavior Analysis. (1976), 9(2):153-157

63. Blackwell, B.: Psychosomatic Aspects of Gastrointestinal Complaints. Journal of the Kentucky Medical Association. (1976), 74(1):26-29.

64. Blackwell, B., Hanenson, I., Bloomfield, S., Magenheim, H., Nidich, S., Gartside, R.: Effects of Transcendental Meditation on Blood Pressure: Individual Response Patterns. Lancet. (1976), 1(7953):223.

65. Blackwell, B.: Prevalence and Variability of Disease: Culture, Morbidity, and Effects of Drugs. Clinical Pharmacology and Therapeutics. (1976), 19(5, Part 2):668-674.

66. Winstead, D., Blackwell, B., Eilers, M.K., Anderson, A.: Psychotropic Drug Use in Five City Hospitals. Diseases of the Nervous System. (1976), 37(9):504- 509.

67. Blackwell, B.: Treatment Adherence in Hypertension. American Journal of Pharmacy and the Sciences Supporting Public Health. (1976), 148(3):75-85.

5 68. Blackwell, B.: Treatment Adherence. British Journal of Psychiatry. (1976), 129:513-531.

69. Blackwell, B.: Medical Education: Old Stresses and New Directions. Pharos. (1977), 40(1):26-30.

70. Whitehead, W.E., Blackwell, B: Why Physicians Prescribe Benzodiazepines in Essential Hypertension. Biological Psychiatry. (1977), 12(4):597-601.

71. Whitehead, W., Blackwell, B., DeSilva, H., and Robinson, A.: Anxiety and Anger in Hypertension. Journal of Psychosomatic Research. (1977), 21(5):383-389.

72. Blackwell, B.: Food and Monoamine Oxidase Inhibitor Interactions. Reviews on Drug Interactions. (1977), 2(2):115-131.

73. Blackwell, B.: Stefopoulos, A., Enders, P., Kuzma, R., and Adolphe, A.: The Anticholinergic Activity of Two Tricyclic Antidepressants. American Journal of Psychiatry. (1978), 135(6):722-724.

74. Whitehead, W., Robinson, A., Blackwell B., Stutz, R.M.: Flooding Treatment of Phobias: Does Chronic Diazepam Increase Effectiveness? Journal of Behavior Therapy and Experimental Psychiatry. (1978), 9:219-225.

75. Whitehead, W., Blackwell, B., and Robinson, A.: Effects of Diazepam on Phobic Avoidance Behavior and Phobic Anxiety. Biological Psychiatry. (1978), 13(3):59-64.

76. Kramer, M., Roth, T., Salis, P., Zorick, F., Blackwell, B.: Relative Efficacy and Safety of Loxapine Succinate (Loxitane) and Thioridazine Hydrochloride (Mellaril) in the Treatment of Acute Schizophrenia. Current Therapeutic Research. (1978), 23(5):619-631.

77. Wooley, S., Blackwell, B., Winget, C.: A Learning Theory Model of Chronic Illness Behavior: Theory, Treatment and Research. Psychosomatic Medicine. (August 1978), 40(5):379-401.

78. Blackwell, B., Griffin, B., Magill, M., and Bencze, R.: Teaching Medical Students About Treatment Compliance. Journal of Medical Education. (1978), 53(8):672-675.

79. Peterson, G.R., Blackwell, B., Hostetter, R.M., Kuzma, R., and Adolphe, A.: Anticholinergic Activity of the Tricyclic Antidepressants Desipramine and Doxepin in Non-Depressed Volunteers. Communications in Psychopharmacology. (1978), 2:145-150.

6 80. Blackwell, B.: Counseling and Compliance. Patient Counseling and Health Education. (1978), 1(2):45-49.

81. Blackwell, B.: Treatment Adherence: A Contemporary Overview. Psychosomatics. (1979), 20(1)27-35.

82. Winstead, D.K., Blackwell, B., and Lawson, T.R.: Psychotropic Drugs: A Biopsychosocial Approach. Family Physician. (1979), 19(1):109-114.

83. Blackwell, B.: Patient Compliance in Primary Care. Family Practice Recertification. (1979), 1(6):68-71.

84. Blackwell, B., Rodin, A.E., Nagy, F., Reece, R.D.: Humanizing the Student Cadaver Encounter. General Hospital Psychiatry. (1979), 1(4):315-321.

85. Blackwell, B., Peterson, G.R., Kuzma, R.J., et al: The Effect of Five Tricyclic Antidepressants on Salivary Flow and Mood in Health Volunteers. Communications in Psychopharmacology. (1980), 4(4):255-261.

86. Wilson, J., Blackwell, B.: Relating Literature to Medicine: Blending Humanism and Science in Medical Education. General Hospital Psychiatry. (1980), 2:127-133.

87. Rehder, T.L., McCoy, L.K., Blackwell, B., Whitehead, W., Robinson, A.: Improving Medication Compliance by Counseling and a Special Prescription Container. American Journal of Hospital Pharmacy. (1980), 37:379-385.

88. Blackwell, B.: What Do We Really Know About Non-Compliance? Consultant. (1981), 21(1):259-266.

88a. Blackwell, B.: What Do We Really Know About Non-Compliance? Extracta Medica Practica. 2(5):415-422. (German Translation)

89. Blackwell, B.: Prescribing for Predicaments. The Art of Medication. (1980), 1(2):10-14.

90. Blackwell, B.: Adverse Effects of Antidepressant Drugs: Part One—Monoamine Oxidase Inhibitors and Tricyclics. Drugs. (1981), 21:201-219.

91. Blackwell, B.: Adverse Effects of Antidepressant Drugs: Part Two—“Second Generation” Antidepressants and Rational Decision-Making in Antidepressant Therapy. Drugs. (1981), 21:273-282.

92. Whitehead, W.E., Winget, C., Fedoravicius, A.S., Wooley, S., and Blackwell, B.: Learned Illness Behavior in Patients with Irritable Bowel Syndrome and Peptic Ulcer. Digestive Diseases and Sciences. (1982), 27:202-208.

7

93. Blackwell, B.: Biofeedback in a Comprehensive Behavioral Medicine Program. Biofeedback and Self-Regulation. (1981), 6(4):445-472.

94. Blackwell, B.: Illness Behavior Labeling and Compliance. Clinical & Investigative Medicine. (1981), 4(3 & 4):209-214. 95. Blackwell, B.: Physician Lifestyle and Medical Marriages. Wisconsin Medical Journal. (1982), 81:23-25.

96. Blackwell, B. and Torem, M.: Behavioral Science Teaching in U.S. Medical Schools: A 1980 National Survey. American Journal of Psychiatry. (1982), 139:1304.

97. Blackwell, B.: Antidepressant Drugs: Side Effects and Compliance. Journal of Clinical Psychiatry. (1982), 43:14.

98. Blackwell, B.: Management of the Depressed Patient: The Art and Science of Compliance. Part I: Update and Overview. JCP Monograph, Physicians Post- Graduate Press. (1982):5-8.

99. Blackwell, B. and Cooperstock, R.: Benzodiazepine Use and the Biopsychosocial Model. Journal of Family Practice. (1983), 17:451.

100. Blackwell, B., Galbraith, J.R., and Dahl, D.S.: Chronic Pain Management. Hospital and Community Psychiatry. (1984), 35:999.

101. Blackwell, B.: A Biopsychosocial Perspective to Psychiatric Drug Use in Pschophysiologic Conditions. Psychopharmacology Bulletin. (1984), 20:629.

102. Blackwell, B. Gutmann, M.C., Jewell, K.E.: Role Adoption in Residency Training. General Hospital Psychiatry. (1984), 6:281.

103. Blackwell, B., Schmidt, G.: Drug Interactions in Psychopharmacology. Psychiatric Clinics of North America. (1984), 7:625.

104. Knapp, C., Blackwell, B.: Emotional and Behavioral Problems in Cardiac Rehabilitation Patients. Journal of Cardiac Rehabilitation. (1985), 5:112-123.

105. Blackwell, B., Simon, JS: Second-Generation Antidepressants. Drugs of Today. (1986), 22:611-633.

106. Blackwell, B.: Antidepressants as Adjuncts in Chronic Idiopathic Pain Management. International Drug Therapy Newsletter. (1987), 22(1):1-4.

107. Blackwell, B., Gutmann, M.: An Illness Behavior Bibliography. Psychiatric Medicine. (1987), 5:171-176.

8

108. Gutmann, M., Sanson-Fisher, R., Christiansen, B., Blackwell, B.: Behavioral Medicine Programs in Teaching Hospitals. Psychotherapy and Psychosomatics. (1987), 48:116-122.

109. Steele, D., Blackwell, B., Gutmann, M., Jackson, T.: Beyond Advocacy: A Review of the Active Patient Concept. Patient Education and Counseling. (1987), 10:3.

110. Blackwell, B., Gutmann, M.: Case Review and Quantity of Outpatient Care. American Journal of Psychiatry. (1988), 145(8):1003-1006.

111. Blackwell, B.: Compliance—Measurement and Intervention. Current Opinion in Psychiatry. (1989), 2:787-789.

112. Blackwell, B.: What is Behavioral Medicine? Medical Encounter. (1989), 6(2):6-7.

113. Hay, D., Hay, L., Blackwell, B., Spiro, H.: ECT and Tardive Dyskinesia. Journal of Geriatric Psychiatry and Neurology. (1990), 3:106-109.

114. Blackwell, B.: Monoamine Oxidase Inhibitor Interactions with Other Drugs. Journal of Clinical Psychopharmacology. (1991), 2(1):55-59.

115. Blackwell, B., Schmidt, G.L.: The Educational Implications of Managed Mental Health Care. Hospital and Community Psychiatry. (1992), 43:962-964.

116. Blackwell, B.: Sick Role Susceptibility. Psychotherapy and Psychosomatics. (1992), 58:79-90.

117. Blackwell, B.: Compliance. Psychotherapy and Psychosomatics. (1992), 58:161-169.

118. Blackwell, B.: From Compliance to Alliance: A Quarter Century of Research. Netherlands Journal of Medicine. (1996), 48:140-149.

119. Blackwell, B., De Morgan, N.: The Primary Care of Patients with Bodily Concerns. Archives of Family Medicine. (1996), 5:457-463.

120. Blackwell, B.: Patients with Somatic Preoccupation in Primary Care. Wisconsin Medical Journal. (1996):840-850. 121. Blackwell, B., Two Sides of the Same Coin. Wisconsin Medical Journal, March 2012.

CREATIVE MEDICAL WRITING

9 1. Blackwell, B.: Primary Care Psychiatry. Journal of the American Medical Association (A Piece of My Mind). (1983), 250:903.

2. Blackwell, B.: Reflections. Psycho. Ann. (1984), 14:3.

3. Blackwell, B.: Dream Doctor. Archives of Internal Medicine. (1984), 144.

4. Blackwell, B.: Tranquility. Wisconsin Medical Journal. (1986), 85(9):18.

5. Blackwell, B.: Twice in a While. Wisconsin Medical Journal. (1986), 85(10):24

6. Blackwell, B.: Light Touch. Annals of Internal Medicine. (1986), 105(5):809.

7. Blackwell, B.: It Only Hurts When I Cry. Wisconsin Medical Journal. (1987), 86(1):28.

8. Blackwell, B.: Don’t Bet On It. Wisconsin Medical Journal. (1987), 86(10):18.

9. Blackwell, B.: Yes and No. Wisconsin Medical Journal. (1987), 86(11):9-10.

10. Blackwell, B.: Baby Boy. Wisconsin Medical Journal. (1987), 86(12):18.

11. Blackwell, B.: Night Owls and Early Birds. Wisconsin Psychiatrist. (Winter, 1994), 17.

BOOK CHAPTERS 1. Marley, E., Blackwell, B.: Interaction of Monoamine Oxidase Inhibitors Amines and Foodstuffs. In Advances in Pharmacology and Chemotherapy. Garattini, S., Boldin, A., Haking, F., and Kopin, I. (Eds.). (1970), 8:185-239.

2. Blackwell, B. Currah, J.: The Psychopharmacology of Nocturnal Enuresis. In Bladder Control and Enuresis. Kolvin, I., MacKeith, R.C., and Meadow, S.R. (Eds.). Clinics in Developmental Medicine. No. 48/49, Spastics International Medical Publication. 1973. London: William Heinemann Medical Books, Ltd. Philadelphia: J.B. Lippincott, Co.

3. Blackwell, B.: Drug Deviation in Psychiatric Patients. In The Future of Psychopharmacotherapy: New Drug Delivery Systems. Ayd, F.J. (Ed.). International Drug Therapy Newsletter. Baltimore. 1973.

4. Blackwell, B.: Early Testing of Psychotropic Drugs in Man: Phase I and Early Phase II. Chapter 1 in Principles and Techniques of Human Research and Therapeutics. Volume VIII Psychopharmacological Agents. Gilbert, F. (Ed.). McMahon, Future Publishing Co. New York. 1974.

10 5. Wright, G.J., Hook, R.H., and Blackwell, B.: Metabolic and Clinical Observations on Metiapine in Humans. In The Phenothiazines and Structurally Related Drugs. Forrest, I.S., Carr, C.J., and Usdin, E. (Eds.). Raven Press. New York. 1974.

6. Blackwell, B.: Rational Drug Use in Psychiatry, Chapter 13 in Rational Psychopharmacotherapy and the Right to Treatment. Ayd, F.J. (Ed.). Ayd Medical Communications. Baltimore. 1975. Also published in International Drug Therapy Newsletter. (1975), 10:13. 7. Blackwell, B., Whitehead, W.E.: Behavioral Evaluation of Anti-Anxiety Drugs. In Predictability in Psychopharmacology—Pre-clinical and Clinical Correlations. Sudilovsky, A., Gershon, S., and Beer, B. (Eds.). Raven Press. New York. 1975.

8. Blackwell, B.: Chemical Coping, Self Control and Compliance in Hypertension. In Medication Compliance: A Behavioral Management Approach. Barofsky, I. (Ed.). C.B. Slack. Thorofare, New Jersey. 1977.

9. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs, 9th Edition. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1977.

10. Whitehead, W.E., Drescher, V.M., Herman, P., and Blackwell, B.: Relation of Heart Rate Control to Heartbeat Perception. In Behavioral Approaches in Medicine: Applications and Analyses. Behaviordelia. 1978. Also in Biofeedback and Self-Regulation. (1977), 2(4):371-392.

11. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 2. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1978.

12. Blackwell, B.: The Drug Regimen and Treatment Compliance. In Compliance with Therapeutic and Preventive Regiments. Hayes, R.B., Taylor, D.W., and Sackett, D.L. (Eds.). Johns Hopkins University Press. Baltimore. 1979.

13. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 3. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1979.

14. Whitehead, W.E., Fedoravicius, A.S., Blackwell, B., Wooley, S.: A Behavioral Conceptualization of Psychosomatic Illness: Psychosomatic Symptoms as Learned Responses. In Behavioral Approaches to Medicine: Application and Analysis. McNamara, J.R. (Ed.). Plenum Press. New York. 1979.

15. Whitehead, W.E., Blackwell, B.: Interactions Between Drugs and Behavior Therapy. In Behavioral Approaches to Medicine: Application and Analysis. McNamara, J.R. (Ed.). Plenum Press. New York. 1979.

11 16. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 4. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1980.

17. Blackwell, B., Torem, M.: The Biopsychosocial Model of Depression. In Clinical Depression: Diagnostic and Therapeutic Challenges. Ayd, S.J. (Ed.). Waverly Press, Inc. Baltimore. 1980.

18. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 5. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1981. 19. Blackwell, B.: Four Case Studies—Hypertension in a 55-Year-Old Woman, 27- Year-Old Presenting Abdominal Pain, Management of Problems in Hypertension, and Recurrent Abdominal Pain. In Adult Psychiatry Case Studies: A Compilation of 55 Clinical Studies. Gulledge, A.D. (Ed.). Medical Examination Publishing Co. New York. 1981.

20. Blackwell, B.: Schizophrenia and Neuroleptic Drugs: A Biopsychosocial Perspective. In the Proceedings from the American Society of Law and Medicine Conference on Refusing Treatment in Mental Health Institutions: Values in Conflict. Doudera, A.E. and Swazey, J.P. (Eds.). AUPHA Press. Ann Arbor. 1982.

21. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 6. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1982.

22. Blackwell, B.: Treatment Compliance. In Treatment of Mental Disorders. Greist, J.H., Jefferson, J.W., Spitzer, R.L. (Eds.). Oxford University Press. New York. 1982.

23. Blackwell, B., Gutmann, M., Jackson, T.: An Update and Overview of Compliance in Hypertension. In Blood Pressure Measurement and Systemic Hypertension. Arntzenius, A.C., Dunnin, A.J., Snellen, H.A. (Eds.). Medical World Press. IMS Breda Holland. 1982.

24. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 7. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1983.

25. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs, 10th Edition. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1982.

26. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 8. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1984.

27. Blackwell, B., Gutmann, M.: Compliance. In Handbook of Hypertension, Vol. 6, Epidemiology of Hypertension. Bulpitt, V.J. (Ed.). Elsevier Science Publishers B.V. 1985.

12

28. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 9. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1985.

29. Blackwell, B.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 10. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1986.

30. Blackwell, B.: Newer Antidepressant Drugs. In Psychopharmacology: The Third Generation of Progress (American College of Neuropsychopharmacology). Meltzer, H.Y. (Ed.). Raven Press. New York. 1987.

31. Blackwell, B.: Side Effects of Antidepressant Drugs. In The American Psychiatric Association Annual Review: Volume 6. Hales, R.E., Frances, A.J. (Eds.). American Psychiatric Press Inc. 1987.

32. Blackwell, B.: Depression in Heart Disease. In Current Therapy in Cardiovascular Disease 1986-1987. Fortuin, N. (Ed.). B.C. Decker Inc. 1987.

33. Blackwell, B., Gutmann, M.: The Management of Chronic Illness Behavior. In Illness Behaviour. McHugh, S., Vallis, M. (Eds.). Plenum Publishing Corp. 1987.

34. Blackwell, B., Simon, J.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 11. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1987.

35. Blackwell, B., Simon, J.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 12. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1988.

36. Blackwell, B., Simon, J.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs, 11th Edition. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1988.

37. Blackwell, B., Merskey, H., Kellner, R.: Somatoform Pain Disorders. In Treatments of Psychiatric Disorders: A Task Force Report of the American Psychiatric Association. Washington, D.C.: American Psychiatric Association. 1989.

38. Blackwell, B.: Chronic Pain. In Comprehensive Textbook of Psychiatry/V. Kaplan, H.I., Sadock, B.J. (Eds.). Williams & Wilkins. 1989.

39. Blackwell, B., Simon, J.: Antidepressant Drugs. In Meyler’s Side Effects of Drugs. Annual 13. Dukes, M.N.G. (Ed.). Excerpta Medica. Amsterdam, Netherlands. 1989.

13

40. Blackwell, B., Breakey, W., Hammersly, D., et al: Psychiatric and Mental Health Services. In Under the Safety Net. Brickner, P.W., et al. (Eds.). WW Norton. New York. 1990.

41. Blackwell, B.: Patient Compliance. In Comprehensive Textbook of Psychiatry/VI. Kaplan, H.I., Sadock, B.J. (Eds.). Williams & Wilkins. 1995. 42. Blackwell, B.: Psychopharmacology for Managed Care Providers. In The Complete Guide to Managed Behavioral Healthcare. Stout C.E., et al. (Eds.). John Wiley & Sons. 1996.

43. Blackwell, B. (Ed.). Treatment Compliance and the Therapeutic Alliance. Harwood Medical Publications. 1997.

44. Blackwell, B., Eilers, K., Robinson, D.: The Consumer’s Role in Assessing Quality. In Handbook of Quality Management in Behavioral Health. Stricker, G., Troy, W., and Shueman, S. (Eds.). Springer. New York. 2001.

ABSTRACTS 1. Blackwell, B., Marley, E.: Hypertensive Interactions between MAOI and Foodstuffs. CINP Congress Reports. (1966), 578-587.

2. Blackwell, B., Taylor, D.: The Use of MAOI and Specific Responses to Them. CINP Congress Reports. (1967), 1083-1086.

3. Blackwell, B., Lipkin, J.O., Meyer, J.H.: The Clinical Pharmacology of Dimethacrin. Federation Proceedings. (1970), 29(2):650.

4. Blackwell, B.: The Chronic Schizophrenic as a Research Subject: Treatment Responsiveness. Psychopharmacology Bulletin. (1970), 6:52.

5. Blackwell, B.: Off the Shelf and Into the Clinic: Placebo in Research. Psychopharmacology Bulletin. (1971), 7(3):62.

6. Berde, B., Blackwell, B., et al.: Report of a Workshop on Fixed-Ratio Drug Combinations. European Journal of Clinical Pharmacology. (1975), 8:149.

7. Wooley, S.C., Blackwell, B., Epps, B., Harper, R.: A Learning Theory Treatment Model for Illness Behavior. Psychosomatic Medicine. (1975), 37:78.

8. Blackwell, B., Hanenson, I., Bloomfield, S., Magenheim, H., Nidich, S., Gartside, P.: Effects of Transcendental Meditation on Blood Pressure: A Controlled Pilot Experiment. Psychosomatic Medicine. (1975), 37:86

14 9. Wooley, S.C., Epps, B., Blackwell, B.: Pain Tolerance in Chronic Illness Behavior. Psychosomatic Medicine. (1975), 37:98.

10. Whitehead, W.E., Lurie, E., Blackwell, B.: Classical Conditioning Facilitates Biofeedback Training to Reduce Blood Pressure in Essential Hypertension. Psychophysiology. (1976), 13:176-177.

11. Whitehead, W.E., Drescher, V.M., Blackwell, B.: Lack of Relationship Between Autonomic Perception Questionnaire Scores and Psychophysiology. Psychophysiology. (1976), 13:177.

12. Blackwell, B.: Psychosomatic Medicine: The Biomedical Approach to Medicine—Is it Enough? The Cincinnati Health Forum. (1976), 2(1):4-6.

13. Blackwell, B.: Patient Compliance in Tricyclic Antidepressant Therapy. Depression Note #19. Merrell National Laboratories. (June, 1976).

14. Blackwell, B., Hanenson, I., Bloomfield, S., Magenheim, H., Nidich, S., Gartside, P.: Transcendental Meditation in Hypertension: Individual Response Patterns. Clinical Medicine. (April, 1977), p. 27.

15. Blackwell, B.: The Social and Behavioral Aspects of Epilepsy. Interchange. Newsletter of the Ohio Rehabilitation Association. (1980), 1(2):3-4.

16. Blackwell, B.: Why Don’t Patients Take Their Medicines? Society for Liaison Psychiatry Newsletter. (1982), 5(1).

17. Blackwell, B.: The Management of Chronic Pain. In Forum. Harvard Medical School Mental Health Letter. (May, 1985), 1(11):8.

18. Blackwell, B.: In the Pipeline: New Drugs. Psychopharmacology Bulletin. 1985, 21(3):357-366.

19. Blackwell, B.: Treatment Work Group. In Functional/Brain-Gut Research Group Newsletter. Issue #10. (April 15, 1993).

ANNOTATIONS AND EDITORIALS 1. Blackwell, B.: Prophylactic Lithium: Science or Science Fiction? American Heart Journal. (1972), 83(1):140-141.

2. Blackwell, B.: Hypertension: Medicate or Meditate? American Heart Journal. (1977), 93(2):262-265.

3. Blackwell, B.: Current Applicable Research: Renal Dialysis for Schizophrenia. Psychiatric Opinion. (1979), 16(1):45.

15 4. Blackwell, B.: Current Applicable Research: Benzodiazepines—Drug or Data Abuse? Psychiatric Opinion. (1979), 16(4):10, 37.

5. Blackwell, B.: Current Applicable Research: The Role of MHPG in Depression. Psychiatric Opinion. (1979), 16(7):2-47.

6. Blackwell, B.: Current Applicable Research: The Endorphins. Psychiatric Opinion. (1979), 16(9):8.

7. Blackwell, B.: From Asylum to Alley. In Touch (Mental Health Association in Milwaukee County). (1985), 7(1).

8. Blackwell, B.: Models: Their Virtues and Vices. Journal of Cardiac Rehabilitation. (1985), 5:169-171.

9. Blackwell, B.: Medical Education and Modest Expectations. General Hospital Psychiatry. (1985), 7:1-3.

10. Blackwell, B.: Prevention of Impairment Among Residents in Training. Journal of the American Medical Association. (1985), 225:1177-1178.

11. Blackwell, B.: What is Behavioral Medicine? Medical Encounter. (1989), 6(2):6-7.

12. Blackwell, B.: In My Opinion: Health Care in Central City Declines to Shameful Levels. The Milwaukee Journal. April 22, 1992.

13. Blackwell, B.: Wearing a White Coat. General Hospital Psychiatry. (1993), 15:90-91.

14. Blackwell, B.: Homelessness and the Mentally Ill. (Letter to the Editor) American Journal of Psychiatry. (June 1993), 150:3.

15. Blackwell, B.: No Margin, No Mission. (A Piece of My Mind) Journal of the American Medical Association. (1994), 271:1466.

BOOKS EDITED Discoveries in Biological Psychiatry. Ayd, F.J. and Blackwell, B. (Eds.). J.P. Lippincott. Philadelphia. 1970. Psychiatric Medicine: Illness Behavior (Volumes I & II). Blackwell, B. and Pilowsky, I. (Guest Editors). Ryandic Publishing. Longwood, Florida. 1987. Psychiatric Case Formulations. Sperry, L., Gudeman, J.E., Blackwell, B., Faulkner L.R. American Psychiatric Press, Inc. Washington, D.C. 1992. Treatment Compliance and the Therapeutic Alliance, APA Press, 1996

MEMOIR

16 Bits and Pieces of a Psychiatrist’s Life (ExLibris, 2012)

OTHER LITERARY CONTRIBUTIONS Numerous book reviews, annotations and leading articles for Lancet, British Journal of Psychiatry and Comprehensive Psychiatry, Psychiatric Opinion, New England Journal of Medicine, and Journal of Nervous and Mental Disease.

PAPERS PRESENTED (1983-1997) Post-Graduate Teaching Course. “The Use of Antidepressants” and “How to Manage Chronic Pain.” Las Vegas, Nevada. February 9-10, 1983.

Columbia Hospital’s Psychiatric Conference. “Chronic Pain Management.” Milwaukee, Wisconsin. February 23, 1983.

Chairman’s Case Conference, Butler Hospital, Brown University. “Illness Behavior.” Providence, Rhode Island. March 2-4, 1983.

Post-Graduate Teaching Course. “The Use of Antidepressants” and “How to Manage Chronic Pain.” Hawaii. March 18-26, 1983.

Fifth Annual Conference and Professional Workshop, Biofeedback Society of Wisconsin. “Biofeedback in a Comprehensive Behavioral Medicine Program.” Milwaukee, Wisconsin. April 23, 1983.

Sixth Annual Symposium, Cardiac Rehabilitation Update 1983. “Illness Behavior in Cardiac Patients.” Milwaukee, Wisconsin. May 4, 1983.

Distinguished Visiting Professor, Lackland Air Force Base, Texas. Included Grand Rounds presentations for the Department of Psychiatry at the University of Texas Health Science Center at San Antonio on “Chronic Illness Behavior: Therapy, Treatment and Research” and a psychology seminar on “Physician Role Adoption.” May 16-21, 1983.

Visiting Professor, United Medical Schools of Guy’s and St. Thomas’ Hospitals, London, England, and University of Manchester, England. May 31-June 10, 1983.

Presentation to Alliance for Mentally Ill of Greater Milwaukee. “Schizophrenia and Neuroleptic Drugs: A Biopsychosocial Perspective.” Milwaukee, Wisconsin. June 27, 1983

17 Presentations on “Illness Behavior”, Geropsychiatry Seminar, Milwaukee County Geropsychiatry Center, Community and Family Aging Services. Milwaukee, Wisconsin. July 13 and 20, 1983.

The Third Annual Green Lake Conference: Medical Advances Affecting the Primary Care Physician. Sponsored by Berlin Memorial Hospital. “Medical Marriages” and “Illness Behavior Patters.” Green Lake, Wisconsin. August 18-19, 1983.

Panelist participating in TV medical debate entitled “Psychotropic Drugs: Their Use and/or Abuse” at Cornell University School of Medicine. New York. September 18, 1983.

Biofeedback Society of Michigan Fall Meeting. “The Role of Biofeedback in a Comprehensive Behavioral Medicine Approach to Chronic Pain.” Participation in panel on “Recent Advances in Pain Management.” Ann Arbor, Michigan. October 29, 1983.

National Institute of Mental Health Workshop on Anxiolytic Drugs as Adjunctive Treatments in Cardiovascular Disease and Gastrointestinal Disorders. “A Biopsychosocial Perspective to Drug Use in Psychophysiologic Conditions.” Washington, D.C. January 19-20, 1984.

Richmond Psychiatric Society. “Illness Behavior: Theory Research and Treatment.” Richmond, Virginia. February 2, 1984.

A.H. Robins Seminar Series. “Cheese and the MAO Inhibitors: A Moral Tale Twice Told.” Richmond, Virginia. February 2, 1984.

Psychiatry Grand Rounds, Medical College of Virginia. “Illness Behavior.” Richmond, Virginia. February 3, 1984.

Visiting Professor, Johns Hopkins University, Baltimore City Hospitals. Grand Rounds: “Chronic Illness Behavior.” General Internal Medicine Dinner: “What to Do With the Worried Well.” Baltimore, Maryland. February 22, 1984.

Medical College of Wisconsin. Seminar in Advanced Psychopharmacology. “Illness Behavior.” Milwaukee, Wisconsin. April 12, 1984.

Guest Lecturer, International Medical Seminars. Egypt. April 19-May 3, 1984.

Seventh Annual Cardiac Rehabilitation Symposium. “Depression and the Cardiac Patient: A Biopsychosocial Approach.” Milwaukee, Wisconsin. May 4, 1984.

18 Mount Sinai Hospital Auxillary. “Color and Mood.” Milwaukee, Wisconsin. May 8, 1984.

The Alliance for the Mentally Ill of Greater Milwaukee. “The Myths of Mental Wellness.” Milwaukee, Wisconsin. May 21, 1984.

Visiting Professor, Cleveland Clinic. Psychiatric Grand Rounds: “What to Do With the Worried Well.” Cleveland, Ohio. May 17, 1984.

Milwaukee County Mental Health Complex. Geropsychiatry In-Service. “The Biopsychosocial Model of Depression.” Milwaukee, Wisconsin. May 30, 1984.

The University of British Columbia. “Cheese and MAO Inhibitors.” Vancouver, British Columbia, Canada. June 7, 1984.

Visiting Professor, Lackland Air Force Base. San Antonio, Texas. June 18-22, 1984.

First International Conference on Clinical and Social Aspects of Illness Behavior. “The Management of Illness Behavior in the Clinical Setting.” Royal Adelaide Hospital. Adelaide, Australia. August 15-18, 1984.

Wisconsin Psychiatric Association, Milwaukee Chapter. Participant in Panel Discussion, “Where is Psychiatry Going, the Academic View.” Milwaukee, Wisconsin. October 10, 1984.

First Unitarian Church. “The Myths of Mental Wellness.” Milwaukee, Wisconsin. October 28, 1984.

Mount Sinai Medical Center Noon Conference. “Drunken Driving.” Milwaukee, Wisconsin. March 5, 1985.

American Nephrology Nurses’ Association. “Chronic Illness Behavior.” Milwaukee, Wisconsin. March 21, 1985.

Guest Lecturer, University of New Mexico. Albuquerque, New Mexico. April 8-9, 1985.

Continuing Medical Education, Inc. Psychiatric Update. “How to Treat Chronic Pain” and “How to Recognize and Deal with the Munchausen Syndrome.” Vancouver, British Columbia, Canada. April 26-28, 1985.

Ninth Annual Cardiac Rehabilitation and Exercise Testing Symposium. Borgess Medical Center. “A Practical Approach to the Treatment of Depression in the Cardiac Patient.” Kalamazoo, Michigan. May 3, 1985.

19 Canadian College of Neuropsychopharmacology. “Biopsychosocial Models of Depression.” The University of Western Ontario, London, Ontario, Canada. May 8, 1985.

Milwaukee Public Library’s “Public Conference.” Panel on “Schizophrenia: Dispelling the Myths.” Channel 6 (CBS Affiliate). Milwaukee, Wisconsin. May 19, 1985.

Second International Conference on Illness Behavior. “The Management of Illness Behavior.” Gut Behavior Unit, Toronto Western Hospital, Toronto, Canada. August 14-16, 1985.

South Central Regional Medical Education Center. “Improving Patient Adherence.” V.A. Medical Center, St. Louis, Missouri. September 24-26, 1985.

Louisville Medical Society. “What to Do With the Worried Well.” Louisville, Kentucky. October 1-3, 1985.

Physician Staff. “Illness Behavior.” Saint Joseph’s Hospital. Milwaukee, Wisconsin. October 9, 1985.

Wisconsin Psychiatric Association Meeting. “Today’s Psychiatrist, Physician, and/or Therapist.” Milwaukee, Wisconsin. October 9, 1985.

Wisconsin Dietetic Association. “MAO Inhibitors.” Oconomowoc, Wisconsin. November 8, 1985.

Carrier Foundation. “Abnormal Illness Behavior.” Belle Mead, New Jersey. January 6- 9, 1986.

American Psychosomatic Society. “Managing the Difficult Medical Patient.” Baltimore, Maryland. March 20-23, 1986.

The Medical College of Pennsylvania. “What to Do With the Worried Sick: Dealing With Learned Illness Behavior.” Philadelphia, Pennsylvania. March 24, 1986.

Grand Rounds Lecturer, Brown University. Providence, Rhode Island. October 2, 1986.

Alliance for the Mentally Ill. “Putting the Family Back in Schizophrenia.” Milwaukee, Wisconsin. October 5, 1986.

Wisconsin Psychiatric Association. “Provider Ethics and Cost Containment.” Brookfield, Wisconsin. October 18, 1986.

University of Wisconsin—Extension. “Psychiatry and Religion: Conscience and Guilt.” Milwaukee, Wisconsin. October 24, 1986.

20 Lilly Research Laboratories Roundtable. Discussant on Fluoxetine Research. Indianapolis, Indiana. November 3-5, 1986.

ACNP 25th Annual Meeting. “New Antidepressant Drugs.” Washington, D.C. December 8-12, 1986.

The University of New Mexico Medical School Department of Psychiatry Journal Club. “A Moral Tale Twice Told: The MAO Inhibitors and Cheese.” Albuquerque, New Mexico. January 9, 1987.

Milwaukee Psychiatric Hospital Continuing Education Series. “Chronic Pain Management.” Milwaukee, Wisconsin. January 28, 1987.

Wisconsin Psychiatric Association 1987 Annual Scientific Meeting. “More Than One Way to Skin a Cat: Personal Reminiscences About Anxiety from an Educational Perspective.” Delevan, Wisconsin. February 12-15, 1987.

Jewish Family and Children’s Service Borderline Personality Disorder Symposium. “Pharmacology.” Milwaukee, Wisconsin. March 12-13, 1987.

APDIM Fourth Annual Workshop for Chief Residents and Program Directors. “Etiology, Prevention, and Management of Emotional Disorders in Residency Training Programs.” New Orleans, Louisiana. April 2, 1987.

Alliance for the Mentally Ill. “Putting the Family Back into Schizophrenia.” Racine, Wisconsin. May 5, 1987.

American Psychiatric Association 1987 Annual Meeting. “Side Effects of Antidepressants.” Chicago, Illinois. May 9-14, 1987.

Cardiovascular Pharmacology Symposium. Moderator for Psychiatric Session. Milwaukee, Wisconsin. June 10, 1987.

Pfizer Pharmaceuticals All-Day Planning Meeting. “Adverse Effects of Antidepressant Drugs.” New York, New York. August 3, 1987.

APDIM Fall Meeting. “Identification of the Impaired Resident” (workshop). Discussant: “Stresses in Medical Residency: Psychiatry Considerations and Program Support.” Philadelphia, Pennsylvania. December 1, 1987.

University of Wisconsin Medical School. Grand Rounds, Department of Psychiatry. “Cheese and MAOIs.” January 1, 1988.

Cooper Hospital/University Medical Center. Grand Rounds, Department of Psychiatry. “Abnormal Illness Behavior.” Camden, New Jersey. January 29, 1988.

21 Allergan Glaucoma Conference. “Psychological Factors Affecting Compliance in Glaucoma Patients.” New York, New York. March 7-8, 1988.

American Psychiatric Association Annual Meeting. Invited discussant of papers on patient compliance and privatization of care. Montreal, Canada. May 11-13, 1988.

University of Southern California School of Medicine. Presentation at the Speakers’ Forum of the Department of Psychiatry: “MAOI and Cheese: A Moral Tale Twice Told. July 12, 1988.

Tulane University Medical Center. Grand Rounds, Department of Psychiatry. “Abnormal Illness Behavior.” New Orleans, Louisiana. October 28, 1988.

Healthcare for the Homeless Fourth Annual Meeting. Served as moderator for session: “Mental Health Treatment Issues Among the Homeless” and panelist for the session: “Primary Health Services.” San Antonio, Texas. November 13-15, 1988.

Second Annual Neuropsychiatry Symposium on Depression: Differential Diagnosis and Treatment. Sponsored by the Departments of Psychiatry and Neurology at Wright State University School of Medicine. “Depression: An Overview.” Dayton, Ohio. December 7, 1988.

University of Manchester. Department of Psychiatry. “Psychiatry and the Homeless.” Manchester, England. January 6, 1989.

Pfizer Pharmaceuticals. Participant at Pfizer’s SM-3997 consultant panel meeting. New York, New York. February 6, 1989.

National Society to Prevent Blindness—Glaucoma Support Group. “Glaucoma Medication Compliance and Coping Skills.” Milwaukee, Wisconsin. February 20, 1989.

Society of Behavioral Medicine Annual Meeting. Moderator of the panel discussion: “Behavioral Medicine: The State of the Field After a Decade.” San Francisco, California. March 29-April1, 1989.

American Psychiatric Association Annual Meeting. Discussant at workshop: “Psychiatric Formulations: Three Converging Models.” San Francisco, California. May 6-11, 1989.

Wisconsin Homeless Conference. Workshop Presentation: “Psychiatric Services to the Homeless.” Saint Norbert College, DePere, Wisconsin. June 6, 1989.

22 Wisconsin Chronic Epstein-Barr Virus Syndrome Association. “The Emotional Aspects of Coping with Chronic Illness.” Milwaukee, Wisconsin. June 10, 1989.

Sinai Samaritan Medical Center, All Staff Conference. “Psychiatric Aspects of Health Care for the Homeless.” Milwaukee, Wisconsin. August 29, 1989.

Homeless Health Care Conference. “The Elderly Homeless: Double Jeopardy.” Arlington, Virginia. October 6, 1989.

Chronic Fatigue Syndrome Great Lakes/Midwest Conference. Conference Moderator. Milwaukee, Wisconsin. October 21, 1989.

Wisconsin Psychiatric Association Fall Meeting. “A Model of Psychiatric Care for the Homeless.” Lake Geneva, Wisconsin. October 29, 1989. Medical College of Pennsylvania. Psychiatry Grand Rounds: “Psychiatric Care for the Homeless.” Evening Symposium: “Cheese and the MAO Inhibitors: A Moral Tale Twice Told.” Philadelphia, Pennsylvania. October 30, 1989.

Guns or Butter: The Social Costs of the Arms Race Conference. Workshop participant: “Taking Care of the Hungry and Homeless in Wisconsin.” University of Wisconsin, Madison. November 11, 1989.

Georgetown University. “Seeing Eye to Eye: Compliance in Glaucoma.” Washington, D.C. January 17, 1990.

The Psychiatric Medical Association of New Mexico. Distinguished Lecturer: “Illness Behavior.” Albuquerque, New Mexico. March 17, 1990.

New Orleans Area Psychiatric Association. “Illness Behavior and Chronic Pain Management.” New Orleans, Louisiana. April 21, 1990.

State Medical Society of Wisconsin Annual Meeting. “Multidisciplinary Health Care for the Homeless.” Green Bay, Wisconsin. April 27, 1990.

Phillips Eye Institute. “Simulations—Patient Compliance in Glaucoma.” Minneapolis, Minnesota. June 4, 1990.

Loyola University. “The Raveled Sleeve of Care: Stress and Impairment in Residency Training.” Maywood, Illinois. September 4, 1990.

Semmons Center on Aging, Jewish Hospital. “Illness Behavior in the Elderly.” Cincinnati, Ohio. September 18, 1990.

Department of Medicine, Sinai Samaritan Medical Center. “Delirium in the Critical Care Setting.” Milwaukee, Wisconsin. October 18, 1990.

23 United Hospital Fund of New York, New York City Coalition for Health Care for the Homeless. “Under the Safety Net: The Health and Social Welfare of Homeless People.” Roundtable Discussion: Mental Illness. New York, New York. November 7, 1990.

National Institute of Mental Health and Wisconsin Nurses Association—Conference on Depression: Awareness, Recognition & Treatment Through the Life Cycle. “Overview of Current Advances in Depression.” Brookfield, Wisconsin. November 16, 1990.

Sinai Samaritan Medical Center. Scientific Day Keynote Address: “Homelessness and Severe Mental Illness: A Social Signpost?” Milwaukee, Wisconsin. June 6, 1991.

Contemporary Pharmacy Practice Fifteenth Annual Seminar. “Compliance Overview and Updates.” Oregon State University. September 21, 1991.

Fall Southeast District Auxillary Meeting. “Homelessness and Severe Mental Illness: A Social Signpost?” Milwaukee, Wisconsin. October 9, 1991.

Marquette University Conference on Homelessness. Discussant on Project Partnership Panel. Milwaukee, Wisconsin. October 11, 1991.

Wisconsin Chronic Fatigue Syndrome Association. “Getting Through the Holidays with CFS.” Milwaukee, Wisconsin. December 14, 1991.

Tulane University Medical Center Grand Rounds. “Homelessness and Severe Mental Illness: A Social Signpost?” New Orleans, Louisiana. January 31, 1992.

Jewish Community Senior Center. “Homelessness and Federal Policy.” Milwaukee, Wisconsin. March 31, 1992.

American Psychosomatic Society 1992 International Meeting. Paper on “Sick Role Susceptibility” presented at Symposium. New York, New York. April 4, 1992.

Health Counseling Services One Day Workshop. “Abnormal Illness Behavior: Models and Management.” Minneapolis, Minnesota. April 9, 1992.

Bulimia Education and Support Training Group (B.E.S.T.). “Psychotropic Drugs: Their Uses in Treating Depression and Anxiety.” Milwaukee, Wisconsin. May 13, 1992.

Medical College of Wisconsin Grand Rounds. “Cheese and the MAO Inhibitors: A Moral Tale Twice Told.” Milwaukee, Wisconsin. May 20, 1992.

24 Wisconsin Association of Outpatient Mental Health Facilities. “Managed Care: Secret Malpractice?” Pewaukee, Wisconsin. May 22, 1992.

Alliance for the Mentally Ill of Greater Milwaukee. “The Big Three: A Look at Major Mental Illnesses.” Milwaukee, Wisconsin. June 1, 1992.

Northeastern Ohio Universities College of Medicine, Department of Psychiatry Grand Rounds. “Overview and Update in Treatment Compliance” and “Psychiatric Formulation: Case Vignettes.” Akron General Medical Center. Akron, Ohio. June 25, 1992.

Workshop on Irritable Bowel Syndrome. National Institute of Diabetes and Digestive Kidney Diseases. Facilitator for “Treatment Research Workgroup.” Bethesda, Maryland. September 9-11, 1992.

Northwestern University Medical School, Department of Psychiatry and Behavioral Sciences Grand Rounds. “Homelessness and Serious Mental Illness: A Social Policy Signpost?” Chicago, Illinois. October 21, 1992.

Alliance for the Mentally Ill, Milwaukee Chapter Keynote Address. “Families and Therapists: Through the Maze Together.” Milwaukee, Wisconsin. October 21, 1992.

Wisconsin Neurological Society, Fall Scientific Program. “Presymptomatic Diagnosis of Huntington’s Disease as a Community Resource.” October 23-24, 1992.

University of Wisconsin—Milwaukee, School of Social Welfare. “Neuroleptic Drugs and Schizophrenia.” Milwaukee, Wisconsin. October 29, 1992.

American Academy of Ophthalmology Meeting. Moderator: “Glaucoma and the Dynamics of Patient Compliance.” Dallas, Texas. November 11, 1992.

Sinai Samaritan, Department of Medicine Grand Rounds. “Confusion about Confusional States.” Milwaukee, Wisconsin. February 12, 1993.

Depressive and Manic Depressive Association (DMDA). “A Biopsychosocial Approach to Understanding and Treatment of Affective Disorders.” Milwaukee, Wisconsin. March 3 and May 5, 1993 (two-part presentation).

Providence Portland Medical Center Grand Rounds. “When Disability is Disproportionate to Disease: The Doctor’s Dilemma.” Portland, Oregon. April 7, 1993.

Statewide Community Support Programs Conference. Workshop: “Engaging Difficult to Serve Clients.” Milwaukee, Wisconsin. April 28, 1993.

25 Wisconsin Alliance for the Mentally Ill. “Homelessness and Serious Mental Illness: A Social Policy Signpost?” Milwaukee, Wisconsin. April 30, 1993.

Family Health Plan 1993 Spring Conference and Workshop. “Evaluation of Acute Changes of Mentation—Confusion and Delirium.” Green Lake, Wisconsin. May 1, 1993.

Grand Avenue Club Presentation. “Side Effects of Psychotropic Drugs.” Milwaukee, Wisconsin. May 12, 1993.

Waukesha Alliance for the Mentally Ill. “The Big Three: A Look at Major Mental Illness.” Pewaukee, Wisconsin. May 26, 1993.

Geriatrics in Primary Care: A Medical Symposium Sponsored by Sinai Samaritan. “Treating Delirium: The Search for Cinderella’s Slipper.” Milwaukee, Wisconsin. June 4, 1993.

Milwaukee Mental Health Insurance Coalition. “Working in Both the Provider and Payor Settings.” Milwaukee, Wisconsin. June 10, 1993.

Saint Luke’s Medical Center Acute Care Lecture Series. “Dangerous/Incompetent Patient Who Wants to Leave.” Milwaukee, Wisconsin. August 6, 1993.

American College of Gastroenterology. “Psychiatric Disorders in GI Patients.” New York, New York. October 5, 1993.

University of Wisconsin Medical School (Milwaukee Clinical Campus) Grand Rounds. “Depression in Primary Care—A Critique of the AHCPR Guidelines.” Sinai Samaritan Medical Center, Milwaukee, Wisconsin. October 8, 1993.

The Second Regional Conference of Psychotherapy Under Managed Care: Outcome- Oriented Treatments of Choice. Pre-Conference Symposium: “Psychopharmacology for Mental Health Professionals.” Washington, D.C. October 28-29, 1993.

Mendota Mental Health Conference Center. “Multiple Personality Disorder.” Milwaukee, Wisconsin. November 12, 1993.

Presentation to the Milwaukee Area Directors of Pastoral Care. “Dialog with a Recent Convert.” Milwaukee, Wisconsin. November 17, 1993.

Controversies in the Management of Colorectal Disorders Conference. “Irritable Bowel Syndrome—What’s New?” Center for Digestive Health Care, University of Wisconsin Medical School, Milwaukee Clinical Campus. Milwaukee, Wisconsin. November 18, 1993.

26 Milwaukee Area Psychological Association. “Homelessness and Serious Mental Illness: A Social Policy Signpost?” Milwaukee, Wisconsin. February 7, 1994.

Resident’s Clinical Lecture. “Illness Behavior.” Saint Luke’s Medical Center. Milwaukee, Wisconsin. March 9, 1994.

Wisconsin Psychiatric Association’s Annual Spring Meeting. “Insurance Perspective.” Madison, Wisconsin. March 25, 1994.

Resident’s Clinical Lecture. “Depression.” Saint Luke’s Medical Center. Milwaukee, Wisconsin. March 30, 1994.

Northeastern Ohio Universities College of Medicine, Department of Psychiatry Grand Rounds. “Overview and Update in Treatment Compliance” and “Psychiatric Formulation: Case Vignettes.” Akron General Medical Center. Akron, Ohio. April 28, 1994.

Veterans Administration Medical Center Grand Rounds. “Homelessness and Serious Mental Illness: A Social Policy Signpost?” Milwaukee, Wisconsin. June 8, 1994.

Saint Luke’s Medical Center Acute Care Lecture Series. “Dangerous/Incompetent Patient Who Wants to Leave.” Milwaukee, Wisconsin. August 2, 1994.

Community Memorial Hospital Presentation. “The Biopsychosocial Approach to Treatment Compliance.” Menomonee Falls, Wisconsin. September 14, 1994.

University of Wisconsin Medical School (Milwaukee Clinical Campus), Department of Obstetrics and Gynecology Grand Rounds. “National Guidelines for Treatment of Depression in Primary Care.” Milwaukee, Wisconsin. October 26, 1994.

Grand Avenue Club Presentation. “Side Effects of Psychotropic Drugs.” Milwaukee, Wisconsin. November 10, 1994.

Saint Joseph’s Hospital, Department of Medicine Grand Rounds. “Management of Depression in the Primary Care Setting.” Milwaukee, Wisconsin. December 14, 1994.

Tulane University Medical Center. Grand Rounds, Department of Psychiatry and Neurology. “Compliance and the Treatment Alliance: A Quarter Century of Research (1970-1995).” New Orleans, Louisiana. February 24, 1995.

Otsuka Speakers Bureau Meeting. “Seeing Eye to Eye: How to Motivate Patients to Comply with Ocular Therapy.” Snowbird, Utah. March 25, 1995.

Roerig-Pfizer Pharmaceutical Company Presentation. “Management of Depression in the Primary Care Setting.” Milwaukee, Wisconsin. March 29, 1995.

27

First International Symposium on Functional Gastro-Intestinal Disorders. “Illness Behavior.” Milwaukee, Wisconsin. April 3-4, 1995.

The Netherlands Society of Internal Medicine Annual Meeting. “From Compliance to Alliance: A Quarter Century of Research.” Eindoven, Netherlands. April 27, 1995.

Multidimensional Clinical Training Workshop, Kenosha County Department of Social Services. “Psychotropic Medications—Practical Considerations for Non-Medical Service Providers.” Milwaukee, Wisconsin. May 18, 1995.

Roerig-Pfizer Pharmaceutical Company Presentation. “Management of Depression in the Primary Care Setting.” Kohler, Wisconsin. June 6, 1995.

Twenty-Third Annual Conference for Nurse Practitioners in Women’s Health. “Pharmacologic Management of Depression.” Milwaukee, Wisconsin. June 9, 1995.

Wisconsin Psychiatric Association’s Fall Conference. “Consultation with Health Management Corporations.” Green Bay, Wisconsin. September 15, 1995.

Providence Portland Medical Center Grand Rounds. “Compliance to Treatment Alliance: A Quarter Century of Research.” Portland, Oregon. May 15, 1996.

36th Annual Meeting of the New Clinical Drug Evaluation Unit Program (NCDEU). Panel Discussant: “Compliance with Maintenance Psychopharmacologic Treatments.” Boca Raton, Florida. May 30, 1996.

Fourth Annual Robert Keller Research Symposium. “Compliance and the Treatment Alliance: A Quarter Century of Research.” Albuquerque, New Mexico. December 6, 1996.

International Conference on Neuropsychology. “Sick Role Susceptibility: Who Behaves Sick, Why and What to Do.” February 5, 1997.

Wisconsin State Annual Community Support Program. “The Therapeutic Triangle.” May 21, 1997.

1998-2007: Numerous talks to lay audiences on mental health related topics.

Barry Blackwell December 4, 2014

28